Literature DB >> 8229679

Effect of phenobarbital and p-hydroxyphenobarbital glucuronide on acetaminophen metabolites in isolated rat hepatocytes: use of a kinetic model to examine the rates of formation and egress.

S D Studenberg1, K L Brouwer.   

Abstract

Conventional analysis of initial uptake and egress rates in isolated hepatocytes is limited in the ability to distinguish between rates of metabolite formation and egress, and to separate basolateral and canalicular transport processes. The present study examined the applicability of kinetic modeling in describing acetaminophen glucuronide (AG) and acetaminophen sulfate (AS) formation and egress in hepatocytes after acute exposure to phenobarbital or p-hydroxyphenobarbital glucuronide (p-OHPBG) in vitro, or in vivo phenobarbital pretreatment. A significant pretreatment effect on AG and AS disposition was seen based on initial rates of egress. In vivo phenobarbital pretreatment decreased the initial egress rate of AG compared to vehicle pretreatment, and the initial egress rate of AS compared to all other treatments. A pharmacokinetic model incorporating AG and AS formation in hepatocytes as well as egress processes (including diffusional and active transport components) was fit to the data. Parameter estimates derived from model fits to the data showed the expected increase in acetaminophen glucuronidation and decrease in sulfation after phenobarbital pretreatment; in addition, an increase in the AG diffusional rate constant and a decrease in the AS diffusional rate constant was apparent. The excretion Vmax for AG was decreased statistically after acute phenobarbital exposure in vitro, and in vivo phenobarbital pretreatment, with a concomitant statistical increase in the Km for AG excretion. In vitro acute p-OHPBG exposure also decreased significantly the excretion Vmax for AG. These data are consistent with the hypothesis that phenobarbital-impaired biliary excretion of AG is a function of impaired canalicular transport due to the presence of p-OHPBG. They further suggest that the mechanism may not be simple competitive inhibition. This work demonstrates the utility of a kinetic modeling approach to differentiate metabolic and transport processes when analyzing data from isolated hepatocyte studies. Additional information may be gained that would not be apparent by conventional methods of analysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8229679     DOI: 10.1007/bf01059769

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  27 in total

1.  Transport of acetaminophen conjugates in isolated rat hepatocytes.

Authors:  S Iida; T Mizuma; N Sakuma; M Hayashi; S Awazu
Journal:  Drug Metab Dispos       Date:  1989 May-Jun       Impact factor: 3.922

2.  Compartmental analysis of steady-state taurocholate transport kinetics by isolated rat hepatocytes.

Authors:  T Coche; X Deroubaix; E Depiereux; E Feytmans
Journal:  Hepatology       Date:  1991-06       Impact factor: 17.425

3.  Biochemical studies on liver functions in primary cultured hepatocytes of adult rats. III. Changes of enzyme activities on cell membranes during culture.

Authors:  S Kato; K Aoyama; T Nakamura; A Ichihara
Journal:  J Biochem       Date:  1979-11       Impact factor: 3.387

4.  Phenacetin and acetaminophen metabolism in the isolated perfused rat liver. Precursor concentration influences the selection of kinetic parameters to assess hypoxic impairment.

Authors:  S D Studenberg; K L Brouwer
Journal:  Drug Metab Dispos       Date:  1991 Mar-Apr       Impact factor: 3.922

5.  Impaired biliary excretion of acetaminophen glucuronide in the isolated perfused rat liver after acute phenobarbital treatment and in vivo phenobarbital pretreatment.

Authors:  S D Studenberg; K L Brouwer
Journal:  J Pharmacol Exp Ther       Date:  1992-06       Impact factor: 4.030

6.  Paracetamol metabolism in the isolated perfused rat liver with further metabolism of a biliary paracetamol conjugate by the small intestine.

Authors:  R Grafström; K Ormstad; P Moldéus; S Orrenius
Journal:  Biochem Pharmacol       Date:  1979-12-15       Impact factor: 5.858

7.  Pharmacokinetic study of the fate of acetaminophen and its conjugates in rats.

Authors:  N Watari; M Iwai; N Kaneniwa
Journal:  J Pharmacokinet Biopharm       Date:  1983-06

8.  Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction.

Authors:  Z Gregus; C Madhu; C D Klaassen
Journal:  Drug Metab Dispos       Date:  1990 Jan-Feb       Impact factor: 3.922

9.  Ethanol as an inducer of UDP-glucuronyltransferase: a comparison with phenobarbital and 3-methylcholanthrene induction in rabbit hepatic microsomes.

Authors:  G S Yost; B L Finley
Journal:  Biochem Biophys Res Commun       Date:  1983-02-28       Impact factor: 3.575

10.  Isolation of rat hepatocyte plasma membranes. I. Presence of the three major domains.

Authors:  A L Hubbard; D A Wall; A Ma
Journal:  J Cell Biol       Date:  1983-01       Impact factor: 10.539

View more
  2 in total

Review 1.  Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity.

Authors:  Brandon Swift; Nathan D Pfeifer; Kim L R Brouwer
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

2.  Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytes.

Authors:  Brandon Swift; Wei Yue; Kim L R Brouwer
Journal:  Pharm Res       Date:  2010-07-22       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.